Director/PDMR Shareholding
Summary by AI BETAClose X
24 February 2026
Optima Health plc
("Optima Health" or the "Company")
Director / PDMR Shareholdings
Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that it was notified on 23 February, that Julia Robertson, (Chairman of the Company) purchased 21,500 Ordinary Shares of £0.01 in the Company ("Ordinary Shares") at a price of 185.00 pence per share.
Following this, Julia Robertson holds an interest of 21,500 Ordinary Shares, representing approximately 0.02% of the current issued share capital.
Enquiries
|
Optima Health Jonathan Thomas, CEO Heidi Giles, CFO
|
+44(0)3300085113 media@OptimaHealth.co.uk |
|
Panmure Liberum Limited Nominated Adviser and Corporate Broker Emma Earl / Will Goode/ Mark Rogers Rupert Dearden
|
+44 (0)20 3100 2000
|
|
Cavendish Capital Markets Joint Broker Geoff Nash/Ben Jeynes/George Lawson Julian Morse/Michael Johnson/Nigel Birks
|
+ 44 (0)20 7220 0500 |
|
ICR Healthcare UK Financial PR Adviser Mary-Jane Elliott / Angela Gray / Lindsey Neville |
optimahealth@icrinc.com
|
About Optima Health
Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 1,600 including 800 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.
In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.
For more information visit www.optimahealth.co.uk
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Julia Robertson |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Chairman |
|||
|
b)
|
Initial notification /Amendment
|
Initial notification |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Optima Health plc |
|||
|
b)
|
LEI
|
213800TOPWJSRCW4ON08 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary Shares of £0.01 each |
|||
|
|
|
||||
|
Identification code |
GB00BRSCY602 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Purchase of shares |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Purchase Price |
Volume |
|
|
|
|
|
185.00 pence |
21,500 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
|
||||
|
- Aggregated volume |
21,500 shares |
||||
|
|
185.00 pence |
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
23 February 2026 |
|||
|
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market |
|||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 12 hours ago Porvair
- 12 hours ago Zinc Media Group
- 12 hours ago Rio Tinto
- 12 hours ago Rio Tinto
- 13 hours ago JPMorgan Asia Growth & Income